Characteristics and Diabetes Control in Adults With Type 1 Diabetes Admitted With COVID-19 Infection.
作者信息
Vamvini Maria, Lioutas Vasileios-Arsenios, Middelbeek Roeland J W
机构信息
Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
出版信息
Diabetes Care. 2020 Oct;43(10):e120-e122. doi: 10.2337/dc20-1540. Epub 2020 Aug 7.
Abstract
摘要
相似文献
1
Characteristics and Diabetes Control in Adults With Type 1 Diabetes Admitted With COVID-19 Infection.1型糖尿病成年患者合并新冠病毒感染时的特征及血糖控制情况
Diabetes Care. 2020 Oct;43(10):e120-e122. doi: 10.2337/dc20-1540. Epub 2020 Aug 7.
2
Pakistan's Combat and Comeback Against COVID-19.巴基斯坦抗击新冠疫情的战斗与复苏
J Diabetes Sci Technol. 2020 Jul;14(4):793-794. doi: 10.1177/1932296820931942. Epub 2020 Jun 6.
3
COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.新冠病毒病（COVID-19）：确诊感染新冠病毒病后再次入院患者的治疗结果
J Infect. 2020 Sep;81(3):e18-e19. doi: 10.1016/j.jinf.2020.07.007. Epub 2020 Jul 8.
4
Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.1型糖尿病与2019冠状病毒病：美国一项多中心监测研究的初步结果
Diabetes Care. 2020 Aug;43(8):e83-e85. doi: 10.2337/dc20-1088. Epub 2020 Jun 5.
5
Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes.新冠疫情封锁期间1型糖尿病成年意大利患者的血糖控制：连续血糖监测指标
Diabetes Care. 2020 Aug;43(8):e88-e89. doi: 10.2337/dc20-1127. Epub 2020 Jun 15.
6
Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection.感染 SARS-CoV-2 后 30 天肺炎患者的功能特征。
Eur Respir J. 2020 Aug 6;56(2). doi: 10.1183/13993003.01754-2020. Print 2020 Aug.
7
Challenges of diabetes management during the COVID-19 pandemic.2019冠状病毒病大流行期间糖尿病管理面临的挑战。
Med J Aust. 2020 Jul;213(2):56-57.e1. doi: 10.5694/mja2.50665. Epub 2020 Jun 24.
8
COVID-19 and type 1 diabetes: Challenges and actions.新冠病毒肺炎与1型糖尿病：挑战与应对措施
Diabetes Res Clin Pract. 2020 Aug;166:108275. doi: 10.1016/j.diabres.2020.108275. Epub 2020 Jun 24.
9
Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?1型糖尿病患者氯喹治疗与低血糖的病例报告：在2019冠状病毒病大流行期间我们应注意什么？
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):355-356. doi: 10.1016/j.dsx.2020.04.014. Epub 2020 Apr 13.
10
COVID-19 and diabetes: Covidiabetology.2019冠状病毒病与糖尿病：新冠糖尿病学
J Pak Med Assoc. 2020 Jun;70(6):954-955.
引用本文的文献
1
Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England.1型糖尿病患者的新冠病毒感染与住院情况：英格兰危险因素分析
Diabetes Ther. 2023 Dec;14(12):2031-2042. doi: 10.1007/s13300-023-01456-8. Epub 2023 Aug 25.
2
Type 1 and type 2 diabetes mellitus: Clinical outcomes due to COVID-19. Protocol of a systematic literature review.1 型和 2 型糖尿病：COVID-19 导致的临床结局。系统文献回顾方案。
PLoS One. 2022 Sep 9;17(9):e0271851. doi: 10.1371/journal.pone.0271851. eCollection 2022.
3
The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review.糖尿病患者中重症2019冠状病毒病进展的潜在机制：一项批判性综述
AIMS Public Health. 2021 Oct 26;8(4):720-742. doi: 10.3934/publichealth.2021057. eCollection 2021.
4
SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophy.先天性全身性脂肪营养不良患者的新型冠状病毒2型感染结局
Diabetol Metab Syndr. 2021 Jun 13;13(1):65. doi: 10.1186/s13098-021-00680-1.
5
A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection.一项针对英国 1 型糖尿病患者因 COVID-19 感染住院的全国性研究。
Diabetologia. 2021 Aug;64(8):1717-1724. doi: 10.1007/s00125-021-05463-x. Epub 2021 May 8.
6
How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?在当前 COVID-19 大流行期间，我们如何推进 1 型糖尿病免疫疗法？
Diabetes. 2021 May;70(5):1021-1028. doi: 10.2337/dbi20-0045. Epub 2021 Feb 25.
7
The association between COVID-19 and type 1 diabetes mellitus: A systematic review.新型冠状病毒肺炎与 1 型糖尿病的相关性：系统综述。
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):447-454. doi: 10.1016/j.dsx.2021.02.009. Epub 2021 Feb 10.
8
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes.COVID-19 在糖尿病患者群体中的严重程度增加了两倍：对 1 型和 2 型糖尿病患者中疫情影响的前瞻性分析。
Diabetes Care. 2021 Feb;44(2):526-532. doi: 10.2337/dc20-2260. Epub 2020 Dec 2.
9
COVID-19 and diabetes mellitus: from pathophysiology to clinical management.新型冠状病毒肺炎与糖尿病：从病理生理学到临床管理。
Nat Rev Endocrinol. 2021 Jan;17(1):11-30. doi: 10.1038/s41574-020-00435-4. Epub 2020 Nov 13.
本文引用的文献
1
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study.1 型和 2 型糖尿病与英格兰 COVID-19 相关死亡率的关联：一项全人群研究。
Lancet Diabetes Endocrinol. 2020 Oct;8(10):813-822. doi: 10.1016/S2213-8587(20)30272-2. Epub 2020 Aug 13.
2
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.在底特律市区的一系列患者中，与 2019 年冠状病毒病相关的临床特征和发病率。
JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270.
3
Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.1型糖尿病与2019冠状病毒病：美国一项多中心监测研究的初步结果
Diabetes Care. 2020 Aug;43(8):e83-e85. doi: 10.2337/dc20-1088. Epub 2020 Jun 5.
4
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.COVID-19 合并糖尿病住院患者的表型特征和预后：CORONADO 研究。
Diabetologia. 2020 Aug;63(8):1500-1515. doi: 10.1007/s00125-020-05180-x. Epub 2020 May 29.
5
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.COVID-19 合并 2 型糖尿病患者的血糖控制与结局的相关性。
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3. doi: 10.1016/j.cmet.2020.04.021. Epub 2020 May 1.
Zotero 插件